Live feed
Filing
SC 13D
SC 13D0000903423-17-000457·Rein Therapeutics, Inc.
Schedule 13D ownership disclosure
AILERON THERAPEUTICS INC
Security class unavailable · CUSIP: 00887A105
Event date: 2017-06-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,431,519
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-17-000457
- Form type
- SC 13D
- Filer
- Rein Therapeutics, Inc.
- CIK
- CIK 1420565
- Filed
- Jul 10, 2017
- Reporting period
- Jun 28, 2017
- Description
- Schedule 13D beneficial ownership